Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / CLASS A COM
-
Total 13F shares
-
76,304,654
-
Share change
-
+1,416,030
-
Total reported value
-
$385,345,044
-
Price per share
-
$5.05
-
Number of holders
-
46
-
Value change
-
+$7,112,345
-
Number of buys
-
29
-
Number of sells
-
7
Institutional Holders of PEAR THERAPEUTICS INC - CLASS A COM (PEARQ) as of Q1 2022
As of 31 Mar 2022,
PEAR THERAPEUTICS INC - CLASS A COM (PEARQ) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,304,654 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, 5AM Venture Management, LLC, SB Global Advisers Ltd, Arboretum Ventures, Inc., TB Alternative Assets Ltd., VANGUARD GROUP INC, Palantir Technologies Inc., PERCEPTIVE ADVISORS LLC, Sarissa Capital Management LP, and EDBI Pte Ltd.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.